L Catterton, the LVMH Moët Hennessy Louis Vuitton-backed private equity firm, has signed a strategic cooperation framework with Mao Geping, the Chinese beauty label. According to a Mao Geping filing on the Hong Kong Stock Exchange, the partnership was formed with L Catterton’s Asia branch and will support the Chinese beauty group’s expansion overseas in high-end retail channels. More from WWD In addition, an equity investment fund will be established by both parties to focus on acquisition and strategic ...

Core Viewpoint - Meiwu Technology Co., Ltd. has signed a non-binding Strategic Cooperation Memorandum of Understanding with Real BioTech to enhance its market share in the beauty industry through a strategic partnership focused on R&D and marine active ingredients [1][2][3] Group 1: Strategic Partnership - The MOU aims to establish a strategic partnership between Meiwu and Real Biotech to expand market shares in the beauty market both in China and globally [1] - Real Biotech will provide R&D support, technical services, and consulting to Meiwu, leveraging its marine biological resources [2] - This collaboration is expected to enhance Meiwu's capabilities in developing beauty solutions that utilize marine active ingredients, a segment driven by increasing consumer demand for natural skincare products [2] Group 2: Long-term Strategy - The partnership aligns with Meiwu's long-term strategy to combine Real Biotech's marine biotechnology expertise with Meiwu's brand operation and distribution network [3] - The collaboration is positioned to capture new opportunities in the evolving beauty industry, delivering enhanced value to customers, shareholders, and partners [3] Group 3: Company Overview - Meiwu Technology Co., Ltd. operates as an integrated platform for R&D, packaging, promotion, sales of functional skincare products, and talent training for retail stores [6] - Real Biotech specializes in marine biotechnology, including R&D, production, and sales of cosmetics and marine biological materials [6]

Core Insights - Liminatus Pharma, Inc. has entered into a Memorandum of Understanding (MOU) with Capital Trust Group Limited for a USD 30,000,000 equity financing to support its immunotherapy research and development [1][2][3] Company Overview - Liminatus Pharma is a clinical-stage immuno-oncology company focused on developing next-generation CD47-blockade therapies, including its proprietary antibody IBA101, aimed at improving treatment for solid tumors [3] Investment Details - The equity financing will be executed through an earn-out mechanism, with funds expected to be remitted after the registration statement for the resale of shares is effective [1][2] - CTG plans to subscribe to newly issued shares of Liminatus, contingent upon compliance with Nasdaq listing rules and U.S. securities laws [2] Future Cooperation - Discussions for further strategic cooperation, including potential digital bond financing programs, are expected to commence in mid-November 2025, pending the signing of definitive agreements [3] Capital Trust Group Overview - Capital Trust Group is a New Zealand-based investment management firm involved in large-scale institutional and blockchain-enabled financing across various sectors, including healthcare [4]

Core Perspective - Keepit has entered into a strategic go-to-market agreement with Ingram Micro to enhance its market presence in Germany and Switzerland [1] Company Summary - Keepit is identified as the world's only independent, cloud-native data protection, backup, and recovery provider [1] - The partnership with Ingram Micro aims to intensify the joint go-to-market strategy in the specified markets [1] Industry Summary - The collaboration reflects a growing trend in the technology ecosystem where B2B platform companies are forming strategic alliances to expand market reach [1]

Core Viewpoint - Senmiao Technology Limited has signed a strategic cooperation agreement with Qinhong International Group to enhance growth and expand its business in the online ride-hailing industry in China [1][3][4] Company Overview - Senmiao Technology Limited, headquartered in Chengdu, Sichuan Province, focuses on automobile transaction services, including sales, financing facilitation, and operating leases in China [4] - Qinhong International Group has been providing financing facilitation support and financial services primarily to small and medium-sized enterprises in Southwest China since its incorporation in 2013 [2] Strategic Cooperation Details - The agreement allows Senmiao to leverage Qinhong's business relationships and customer resources across China [3] - Qinhong will assist Senmiao in securing financing through its extensive relationships with banks and financial institutions when needed [3] Management Perspective - The Chairman and CEO of Senmiao expressed that the cooperation with Qinhong represents a new growth opportunity, aiming to share resources, expand the customer base, and boost revenues [4]